from Vitruvia Medical AG (isin : CH0461931419)
EQS-Adhoc: Vitruvia Medical AG: auhtorised capital increase
EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Capital Increase
Vitruvia Medical AG: auhtorised capital increase
27-March-2023 / 11:34 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Ad Hoc Announcement
Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1'680'817.50 were offset, for which 672'327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now amounts to CHF 2,511,578.00.
Vitruvia Medical AG
Markus A. Bertschin
Chairman of the Board of Directors
27-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 1593069 |
| End of Announcement | EQS News Service |
1593069 27-March-2023 CET/CEST